Core Viewpoint - Beijing Ruimait Medical Technology Co., Ltd. is experiencing growth in revenue and profit, driven by its focus on respiratory health devices and benefiting from the depreciation of the RMB [3][8]. Company Overview - The company is located in Beijing and specializes in manufacturing medical devices and consumables in the respiratory health field, including various types of sleep breathing machines and monitoring devices [2][7]. - The main revenue sources are home respiratory therapy products (64.19%), consumables (32.67%), and medical products (3.05%) [7]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 808 million yuan, representing a year-on-year growth of 34.24%, and a net profit attributable to shareholders of 180 million yuan, up 43.87% year-on-year [8]. - As of September 30, 2025, the company had a total of 7,971 shareholders, an increase of 16.36% from the previous period [8]. Market Position and Investment - The company holds a 14.28% stake in Deda Xing Drive, a leading domestic provider of precision motors and solutions, which enhances its capabilities in AI, robotics, and medical applications [3]. - The company’s overseas revenue accounts for 64.21%, benefiting from the depreciation of the RMB [3]. Stock Performance - On December 26, the stock price of Ruimait fell by 0.97%, with a trading volume of 47.18 million yuan and a market capitalization of 7.48 billion yuan [1].
瑞迈特跌0.97%，成交额4718.38万元，近3日主力净流入947.73万